Jounce Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Jounce Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2022.
  • Jounce Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2022 was $2.44M, a 12.5% decline year-over-year.
  • Jounce Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2022 was $10.3M, a 10.5% decline year-over-year.
  • Jounce Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.3M, a 10.5% decline from 2021.
  • Jounce Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.5M, a 17.5% increase from 2020.
  • Jounce Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $9.77M, a 1.69% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $10.3M -$1.2M -10.5% Jan 1, 2022 Dec 31, 2022 10-K/A 2023-04-28
2021 $11.5M +$1.71M +17.5% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-04-28
2020 $9.77M +$162K +1.69% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $9.61M +$202K +2.15% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 $9.41M +$4.63M +97% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 $4.78M -$214K -4.29% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 $4.99M +$3.64M +269% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-08
2015 $1.35M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.